COSY: Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants

Sponsor
University of Cologne (Other)
Overall Status
Recruiting
CT.gov ID
NCT05975203
Collaborator
(none)
60
1
2
40.9
1.5

Study Details

Study Description

Brief Summary

The goal of this randomized controlled trial is to compare the effect of direct skin-to-skin contact in moderate and late preterm infants. The main questions it aims to answer are:

  • does skin-to-skin contact in moderate and late preterm infants influence gene expression in the stress signaling pathway?

  • does skin-to-skin contact in moderate and late preterm infants improve the short- and long-term outcome?

Participants will either get immediate separation after vaginal birth or receive immediate skin-to-skin contact. Researchers will compare these two groups to answer the proposed questions.

Condition or Disease Intervention/Treatment Phase
  • Procedure: skin-to-skin contact
N/A

Detailed Description

The planned study investigates prospectively the effect of early intervention (skin-to-skin contact in the delivery room) in moderate and late preterm infants on neonatal programming by determining gene expression in the stress signaling pathway. The working hypothesis of our project is that the intervention will affect gene expression in a way that subsequently leads to better long-term psycho-social and neurological development of these preterm infants. The study aims to improve the understanding of the correlation of behavioral and epigenetic parameters and prove the underlying hypothesis of a novel mechanistic link between immediate skin-to-skin contact in the delivery room and life-long stress tolerance.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Due to the nature of the intervention blinding of participant and care provider is not possible. The investigators are part of the care providing team.
Primary Purpose:
Treatment
Official Title:
Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants
Actual Study Start Date :
Aug 4, 2023
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard care

After delivery the infant will be separated from the mother and placed on a primary care unit in another room to monitor the cardiopulmonary adaption for at least 20 minutes.

Experimental: skin-to-skin contact

After delivery the infant will be put skin-to-skin on the mother's breast in comfort position for 60 minutes. The cardiopulmonary adaption will be monitored and supervised by the attending neonatologist and nurse.

Procedure: skin-to-skin contact
Immediately after delivery the infant will receive skin-to-skin contact with the mother.

Outcome Measures

Primary Outcome Measures

  1. gene expression in candidate genes of the stress signalling pathway [36 to 72 hours after birth]

    DNA will be extracted from peripheral white blood cells and mucosal epithelial cells. The expression of candidate genes of the stress signaling pathways are investigated. The candidate genes are glucocorticoid receptor (NR3C1), corticotropin releasing hormone (CRH), corticotropin-releasing hormone receptor 1 and 2 (CRHR1/2), serotonin transporter (slc6a4), vasopressin and brain-derived neurotrophic factor.

  2. gene expression in candidate genes of the stress signalling pathway [corrected 6 months of age]

    DNA and RNA will be extracted from mucosal epithelial cells. The expression of candidate genes of the stress signaling pathways are investigated. The candidate genes are glucocorticoid receptor (NR3C1), corticotropin releasing hormone (CRH), corticotropin-releasing hormone receptor 1 and 2 (CRHR1/2), serotonin transporter (slc6a4), vasopressin and brain-derived neurotrophic factor. Furthermore a whole-genome methylation will be analysed.

  3. gene expression in candidate genes of the stress signalling pathway [corrected 24 months of age]

    DNA will be extracted from mucosal epithelial cells. The expression of candidate genes of the stress signaling pathways are investigated. The candidate genes are glucocorticoid receptor (NR3C1), corticotropin releasing hormone (CRH), corticotropin-releasing hormone receptor 1 and 2 (CRHR1/2), serotonin transporter (slc6a4), vasopressin and brain-derived neurotrophic factor.

Secondary Outcome Measures

  1. mother-child-interaction [corrected 6 months of age]

    Mother-child-interaction is investigated using Mannheim Rating Scales. Therefore a five-minute-videotape of the mother changing the infant's diapers and playing with the infant is used. Mannheim Rating Scales is a good validated standardized observation instrument. Stimulation and response from the mother as well from the infant are being recorded. Different communication channels can be used by mother and child (vocal, facial or motor). All behaviors are analysed at intervals of five seconds (event coding). Then the values are formed from the sum of the coded events. The scale ranges from 0 to 60. If there is no interaction, the scale is 0. If there is an interaction in each interval (every 5 seconds in a 5 minute videotape), the scale is 60. The mother-child interaction is better if the scale is higher.

  2. General Movements [corrected 3 months of age]

    The early infant development will be analyzed by general movements assessment by Prechtl. It is a validated diagnostic tool for the functional assessment of the young nervous system.

  3. maternal depression [at inpatient discharge (assessed from 3 to 60 days of life), corrected 6 and 24 months of age]

    Maternal depression is assessed with the German long form of the Center for Epidemiological Studies Depression Scale (CES-D). It is a self-report questionnaire to measure depressive symptoms and it consists of 20 questions. For each question the response choice are assigned point values (how often a symptom occurred during the last week). The point values are summed to a total measure score. The score ranges from 0 to 60. Zero points represents no symptoms of depression, a score of 15 or higher is interpreted to indicate a risk of depression.

  4. social support [at inpatient discharge (assessed from 3 to 60 days of life), corrected 24 months of age]

    Social support is assessed with the short version of the German questionnaire for social support (Fragebogen zur sozialen Unterstützung, questionnaire on social support) scale (F-SozU K-22). The questionnaire records the subjectively perceived or anticipated support from the social environment. There are 22 items and the test person can indicate the degree of agreement on a five-level Likert scale (from 1 = does not apply to 5 = applies completely). The scale ranges from a minimum of 22 points to a maximum of 110 points. The higher the score, the better the subjectively perceived or anticipated support.

  5. socio-economic status [at inpatient discharge (assessed from 3 to 60 days of life)]

    There will be a question to the household income per month and the parents' highest school-leaving certificate as well as the housing situation.

  6. breastfeeding [at inpatient discharge (assessed from 3 to 60 days of life) and corrected six months of age]

    There will be a question about breastfeeding.

  7. impact of event scale [corrected 6 months of age]

    Symptoms for post-traumatic stress is assessed with the impact of event scale - revised (IES-R). It is a self-report questionnaire and consists of 22 questions. For each question the response choice are assigned point values (how often a symptom occurred during the last week). The sub-scale values are summed by the corresponding sub-scale items. The three sub-scales are: intrusion, avoidance and hyperarousal. The overall result is calculated by a formula. The score ranges from -4,36 to 2,99. A result above 0 is interpreted to indicate a risk of post-traumatic stress disorder.

  8. Parental Bonding [corrected 6 and 24 months of age]

    Parental Bonding is assessed with the parental bonding questionnaire (PBQ). It consists of 25 items and each item is rated on a scale from 0 to 3 points (response range from "very like" to "very unlike"). There are four sub-scales and the point values of each sub-scale are summed to a total measure score. The four sub-scales are: impaired bonding, rejection and anger, anxiety about care, risk of abuse. The higher the score, the higher the risk of a disorder in each area of the sub-scale.

  9. Parental Stress [corrected 6 and 24 months of age]

    Parental stress is assessed with the German form of the parenting stress index (PSI). It consists of 48 items. The test person can indicate the degree of agreement on a five-level Likert scale (from 1 = does not apply to 5 = applies completely). There are 12 subscales, each consisting of 4 items and the points on the Likert scale are added. In each subscale there can be a minimum of 4 and a maximum of 20 points. The higher the score, the higher the parental stress.

  10. reactivity of hypothalamic-pituitary-adrenal-axis [36 to 72 hours after birth and corrected 24 months of age]

    Salivary cortisol is measured before and 20 minutes after heel lance, respectively after a stressful testing. The saliva is collected by a small cotton roll, which is placed in the infants' mouth. The cortisol is assayed in duplicate using an immunoassay, which is a validated test.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • preterm birth between gestational age of 32 0/7 and 36 6/7 weeks

  • first child

  • vaginal delivery

  • singleton

  • informed consent before birth

Exclusion Criteria:
  • malformations or syndromes of the infant

  • resuscitation of the infant

  • maternal psychological or severe physical illness

  • lack of German language skills

Contacts and Locations

Locations

Site City State Country Postal Code
1 University hospital of Cologne, Department of Neonatology Cologne Northrhine-westfalia Germany 50931

Sponsors and Collaborators

  • University of Cologne

Investigators

  • Principal Investigator: Katrin Mehler, PD Dr., University of Cologne

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Katrin Mehler, Associate Professor, University of Cologne
ClinicalTrials.gov Identifier:
NCT05975203
Other Study ID Numbers:
  • 22-1419
First Posted:
Aug 3, 2023
Last Update Posted:
Aug 7, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Katrin Mehler, Associate Professor, University of Cologne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2023